InvestorsHub Logo
Followers 829
Posts 119626
Boards Moderated 14
Alias Born 09/05/2002

Re: None

Tuesday, 11/02/2021 9:15:41 AM

Tuesday, November 02, 2021 9:15:41 AM

Post# of 247
EOLS starting "double-dose" phase-2 trial in glabellar lines to see if it can extend the duration of effect:

https://investors.evolus.com/news-releases/news-release-details/evolus-initiates-phase-ii-program-extra-strength-dose-extended

Results of the phase-2 trial will be available in 2023.

The idea won’t work, of course. RVNC Daxi’s extended duration comes from its peptide formulation, not from using a higher dose; however, the “higher dose” canard remains popular among RVNC’s competitors.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent EOLS News